A61K 39/155
Paramyxoviridae
Official title: Paramyxoviridae, e.g. parainfluenza virus
A61K39/155 (Paramyxoviridae) appears on 746 US grants and 1,067 published applications in this corpus.
Search patents in A61K- Granted patents
- 746
- Published applications
- 1,067
- Assignees
- 455
- Inventors
- 1,778
- Latest grant
- 8 Sep 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 2 | 0 |
| 1977 | 2 | 0 |
| 1978 | 3 | 0 |
| 1979 | 2 | 0 |
| 1980 | 4 | 0 |
| 1981 | 3 | 0 |
| 1982 | 4 | 0 |
| 1983 | 0 | 0 |
| 1984 | 0 | 0 |
| 1985 | 4 | 0 |
| 1986 | 0 | 0 |
| 1987 | 1 | 0 |
| 1988 | 0 | 0 |
| 1989 | 1 | 0 |
| 1990 | 0 | 0 |
| 1991 | 8 | 0 |
| 1992 | 6 | 0 |
| 1993 | 2 | 0 |
| 1994 | 0 | 0 |
| 1995 | 2 | 0 |
| 1996 | 0 | 0 |
| 1997 | 2 | 0 |
| 1998 | 10 | 0 |
| 1999 | 10 | 0 |
| 2000 | 11 | 0 |
| 2001 | 14 | 2 |
| 2002 | 9 | 15 |
| 2003 | 13 | 27 |
| 2004 | 12 | 23 |
| 2005 | 8 | 25 |
| 2006 | 7 | 18 |
| 2007 | 10 | 22 |
| 2008 | 11 | 16 |
| 2009 | 13 | 26 |
| 2010 | 19 | 43 |
| 2011 | 8 | 37 |
| 2012 | 6 | 34 |
| 2013 | 13 | 32 |
| 2014 | 22 | 62 |
| 2015 | 42 | 54 |
| 2016 | 42 | 73 |
| 2017 | 52 | 56 |
| 2018 | 45 | 55 |
| 2019 | 62 | 59 |
| 2020 | 46 | 64 |
| 2021 | 44 | 55 |
| 2022 | 38 | 58 |
| 2023 | 35 | 58 |
| 2024 | 39 | 64 |
| 2025 | 38 | 42 |
| 2026 | 21 | 47 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Subgroups
Granted patents
Recent patents
- Use of membrane inhibitors to enhance vaccine development against enveloped viruses8 Sep 2026US 12,728,161 B2Cornell University
- Conformationally stabilized RSV pre-fusion F proteins11 Aug 2026US 12,703,721 B2
- Respiratory syncytial virus (RSV) polyanhydride nanoparticle vaccine14 Jul 2026US 12,678,410 B2University of Iowa Research Foundation
- Recombinant human metapneumovirus F proteins and their use14 Jul 2026US 12,679,870 B2The United States of America, as represented by the Secretary, Department of Health and Human Services
- Measles virus vaccine expressing SARS-CoV-2 protein(s)16 Jun 2026US 12,653,881 B2University of Pittsburgh—Of the Commonwealth System of Higher Education
- Inhaled adenovirus vector vaccine, preparation method therefor and use thereof8 Oct 2026US 2026/0306605 A1Cansino Biologics Inc.
- Prefusion-stabilized human parainfluenza virus 3 f proteins8 Oct 2026US 2026/0306613 A1Board of Regents, The University of Texas System
- Nucleic acid-lipid nanoparticle composition, and lyophilized preparation thereof, preparation method therefor and use thereof1 Oct 2026US 2026/0294829 A1Cansino Biologics Inc.
- Compositions and methods for the treatment of immunodeficiency24 Sep 2026US 2026/0285950 A1Adma Biomanufacturing, LLC
- Modified virus-like particles of cmv10 Sep 2026US 2026/0263612 A1Saiba GmbH
Most cited
By later US patents
- Immunotherapy of epithelial tumors using intralesional injection of antigens that induce a delayed type hypersensitivity reaction188US 6,350,451 B1Board of Trustees of the University of Arkansas · 2002
- Nucleic acid vaccines165US 9,872,900 B2ModernaTX, Inc. · 2018
- GITR-binding antibodies141US 7,812,135 B2TolerRx, Inc. · 2010
- Canarypox virus expressing cytokine and/or tumor-associated antigen DNA sequence128US 5,833,975 AVirogenetics Corporation · 1998
- Methods for inducing or enhancing an immune response by administering agonistic GITR-binding antibodies121US 8,388,967 B2GITR, Inc. · 2013